Acquisitions jump in clinical trial operations in H2
The highest value acquisition in 2021 was the $12.3m acquisition of Vifor Pharma by CSL.
By
IPO Industry
Latest in
IPO Industry
NuvoAir secures additional $11m Series A raise for clinical trials platform
NuvoAir will unitise the funds to accelerate the clinical services launch with risk-bearing providers and Health Plans.
Veeva bolsters clinical suite with Veracity Logic acquisition
Offering quick setup timelines, the Veeva RTSM solution has so far supported more than 175 trials with sites in 60…
Hunting the unicorns: GlobalData IPO predictions for 2022
10 tech unicorns that are likely going enjoy a headline-making IPO in 2022, following GlobalData's predictions.
By
Innovation Fund Denmark: attracting investment in clinical trials
Innovation Fund Denmark invests in high-risk, high-potential innovation to improve the lives of the Danish population.
By
BEKHealth receives funds to boost AI clinical research
BEKHealth will use the proceeds to extend its team and meet the growing demand from clients.
Australia’s first local Covid-19 vaccine gets funding for Phase I trials
The investment is the first from the fund to boost Victoria state’s mRNA manufacturing capability.
HumanFirst secures funding to support clinical trials at home
HumanFirst is expanding offerings with the new funding, as decentralised clinical trials have grown in the past year.